Pay in 4 interest-free payments of $5.18 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
* Compensated Hone Patient Start with a deeper look at your health Identifying your unique needs begins with analysis, including in-depth, 50-biomarker blood testing, personal health history, and validated questionnaires
R Clinical implications of slow acetylation: Increased risk of isoniazid-induced hepatotoxicity and peripheral neuropathy (tuberculosis treatment) R Increased risk of sulfonamide hypersensitivity reactions R Increased risk of aromatic amine-related bladder cancer in occupational exposure settings (dye workers, rubber industry) R Drug-induced lupus from hydralazine and procainamide occurs almost exclusively in slow acetylators R Altered caffeine metabolism (slow acetylators clear caffeine more slowly via the NAT2 pathway) R NAT1 polymorphisms are less well characterized but the slow allele NAT1*14 has been associated with increased risk of cancers from dietary aromatic amines
This technical expertise ensures that the finished product retains potency throughout the entire shelf life for the consumer
In contrast, the levels of cytokines involved in the control of melanocyte proliferation and differentiation and the inhibition of melanogenesis, IL-17, IL-4 and IL-6, were significantly increased in the vitiligo group compared with the control group
